These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 6610647

  • 1. Synthesis and in vivo distribution in rat brain of 11C-labelled N-alkylated ADTN derivatives.
    van der Werf JF, Vaalburg W, Korf J, Kuilman T, Wiegman T.
    Int J Appl Radiat Isot; 1984 May; 35(5):377-81. PubMed ID: 6610647
    [Abstract] [Full Text] [Related]

  • 2. 6,7-Dihydroxy-3-chromanamine: synthesis and pharmacological activity of an oxygen isostere of the dopamine agonist 6,7-dihydroxy-2-aminotetralin.
    Horn AS, Kaptein B, Mulder TB, de Vries JB, Wynberg H.
    J Med Chem; 1984 Oct; 27(10):1340-3. PubMed ID: 6090664
    [Abstract] [Full Text] [Related]

  • 3. Brain levels and metabolism of the dopaminergic agonist 2-amino-6,7-dihydroxytetrahydronaphthalene after administration of various prodrugs.
    Horn AS, Griever-Kazemier H, Dijkstra D.
    J Med Chem; 1982 Aug; 25(8):993-6. PubMed ID: 7120289
    [Abstract] [Full Text] [Related]

  • 4. Effects of ADTN and various other 2-aminotetralin derivatives on the efflux of 3H-dopamine from rat striatal slices.
    Mulder AH, Braakhuis B, De Regt V, Dijkstra D, Horn AS.
    Eur J Pharmacol; 1980 Jun 27; 64(4):349-55. PubMed ID: 7389827
    [Abstract] [Full Text] [Related]

  • 5. (+)-cis-8-Hydroxy-1-methyl-2-(di-n-propylamino)tetralin: a potent and highly stereoselective 5-hydroxytryptamine receptor agonist.
    Arvidsson LE, Johansson AM, Hacksell U, Nilsson JL, Svensson K, Hjorth S, Magnusson T, Carlsson A, Andersson B, Wikström H.
    J Med Chem; 1987 Nov 27; 30(11):2105-9. PubMed ID: 2959776
    [Abstract] [Full Text] [Related]

  • 6. In vivo dopamine receptor agonist binding in rat brain: relation with pharmacological effects.
    Feenstra MG, Rollema H, Mulder TB, De Vries JB, Horn AS.
    Eur J Pharmacol; 1983 Jun 17; 90(4):433-6. PubMed ID: 6684056
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The significance of COMT activity in controlling dopamine agonist levels in brain and serum: studies with a prodrug and a metabolite of 6,7-ADTN.
    Rollema H, Westerink BH, Mulder TB, Dijkstra D, Feenstra MG, Horn AS.
    Eur J Pharmacol; 1980 Jun 27; 64(4):313-23. PubMed ID: 7389825
    [Abstract] [Full Text] [Related]

  • 9. Resolved cis- and trans-2-amino-5-methoxy-1-methyltetralins: central dopamine receptor agonists and antagonists.
    Johansson AM, Arvidsson LE, Hacksell U, Nilsson JL, Svensson K, Carlsson A.
    J Med Chem; 1987 Apr 27; 30(4):602-11. PubMed ID: 3560156
    [Abstract] [Full Text] [Related]

  • 10. Synthesis and dopaminergic activity of some halogenated mono- and dihydroxylated 2-aminotetralins.
    Weinstock J, Gaitanopoulos DE, Oh HJ, Pfeiffer FR, Karash CB, Venslavsky JW, Sarau HM, Flaim KE, Hieble JP, Kaiser C.
    J Med Chem; 1986 Sep 27; 29(9):1615-27. PubMed ID: 2875183
    [Abstract] [Full Text] [Related]

  • 11. In vivo dopamine receptor binding studies with a non-radioactively labeled agonist, dipropyl-5,6-ADTN.
    Feenstra MG, Rollema H, Mulder TB, Westerink BH, Horn AS.
    Life Sci; 1983 Mar 21; 32(12):1313-23. PubMed ID: 6403788
    [Abstract] [Full Text] [Related]

  • 12. C1-Methylated 5-hydroxy-2-(dipropylamino)tetralins: central dopamine-receptor stimulating activity.
    Hacksell U, Johansson AM, Arvidsson L, Nilsson JL, Hjorth S, Carlsson A, Wikström H, Sanchez D, Lindberg P.
    J Med Chem; 1984 Aug 21; 27(8):1003-7. PubMed ID: 6431102
    [Abstract] [Full Text] [Related]

  • 13. Selective storage in vivo of 5,6-ADTN in dopamine-rich areas of the rat brain.
    Westerink BH, Dijkstra D, Feenstra MG, Horn AS, Rollema H.
    Eur J Pharmacol; 1980 Jun 13; 64(2-3):115-21. PubMed ID: 7398758
    [Abstract] [Full Text] [Related]

  • 14. 5-Hydroxy-2-methyl-2-(di-n-propylamino)tetralin: synthesis and central pharmacological effects.
    Hacksell U, Arvidsson LE, Johansson AM, Nilsson JL, Sanchez D, Andersson B, Lindberg P, Wikström H, Hjorth S, Svensson K.
    Acta Pharm Suec; 1985 Jun 13; 22(2):65-74. PubMed ID: 2996294
    [No Abstract] [Full Text] [Related]

  • 15. C(2)-Methylation abolishes DA1 dopamine agonist activity of 2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene (6,7-ADTN): steric intolerance by the receptor.
    Nichols DE, Jacob JN, Hoffman AJ, Kohli JD, Glock D.
    J Med Chem; 1984 Dec 13; 27(12):1701-5. PubMed ID: 6502600
    [Abstract] [Full Text] [Related]

  • 16. A C2-methylated derivative of the 5-hydroxy-tryptamine-receptor agonist 8-hydroxy-2-(dipropylamino)tetralin (8-OH DPAT).
    Mellin C, Liu Y, Hacksell U, Björk L, Andén NE.
    Acta Pharm Suec; 1987 Dec 13; 24(4):153-60. PubMed ID: 2964167
    [No Abstract] [Full Text] [Related]

  • 17. S(-)DP-5,6-ADTN as an in vivo dopamine receptor ligand: relation between displacement by dopamine agonists and their pharmacological effects.
    Rollema H, Feenstra MG, Grol CJ, Lewis MH, Staples L, Mailman RB.
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Apr 13; 332(4):338-45. PubMed ID: 3736679
    [Abstract] [Full Text] [Related]

  • 18. Binding of [3H]ADTN to rat striatal membranes.
    Templeton WW, Woodruff GN.
    Biochem Pharmacol; 1982 Apr 15; 31(8):1629-32. PubMed ID: 6124259
    [Abstract] [Full Text] [Related]

  • 19. Central dopaminergic and 5-hydroxytryptaminergic effects of C3-methylated derivatives of 8-hydroxy-2-(di-n-propylamino)tetralin.
    Mellin C, Björk L, Karlén A, Johansson AM, Sundell S, Kenne L, Nelson DL, Andén NE, Hacksell U.
    J Med Chem; 1988 Jun 15; 31(6):1130-40. PubMed ID: 2967376
    [Abstract] [Full Text] [Related]

  • 20. 2-(Alkylamino)tetralin derivatives: interaction with 5-HT1A serotonin binding sites.
    Naiman N, Lyon RA, Bullock AE, Rydelek LT, Titeler M, Glennon RA.
    J Med Chem; 1989 Jan 15; 32(1):253-6. PubMed ID: 2521252
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.